Science & Enterprise subscription

Please share Science & Enterprise

RSS
Follow by Email
Facebook
Facebook
Google+
Twitter
Visit Us
LinkedIn

Affiliations

Neuro Disease Start-Up Gains $30M in Early Funds

A start-up enterprise developing treatments for several neurological diseases that the company says are triggered by a common destructive protein, is raising $30 million its first venture financing round. . . . → Read More: Neuro Disease Start-Up Gains $30M in Early Funds

Drug Delivery Technology Licensed in $2B Deals

The biotechnology company Halozyme Therapeutics Inc. is licensing its technology for making infusion drugs deliverable with injections to two more drug makers. . . . → Read More: Drug Delivery Technology Licensed in $2B Deals

Trial Shows Antibody Effective Against Asthma

Results from a large-scale clinical trial show a synthetic antibody, when added to standard treatments, reduces asthma attacks and improves lung functioning. . . . → Read More: Trial Shows Antibody Effective Against Asthma

Trial Underway Testing Alzheimer’s-Schizophrenia Drug

A new clinical trial began in the U.K. in a test of an experimental drug to treat schizophrenia associated with Alzheimer’s disease. . . . → Read More: Trial Underway Testing Alzheimer’s-Schizophrenia Drug

Engineered T-Cell Company Acquired for $11.9 Billion

A company developing personal cancer therapies that genetically engineer a patient’s immune system cells is being acquired in a deal valued at $11.9 billion. . . . → Read More: Engineered T-Cell Company Acquired for $11.9 Billion

AstraZeneca, Biotech Partner on Messenger RNA Therapies

Global drug maker AstraZeneca is acquiring an option to license the rights to a technology based on genetic material transcribed from DNA, for new respiratory disease treatments. . . . → Read More: AstraZeneca, Biotech Partner on Messenger RNA Therapies

Peptide Immunotherapy Shown Safe for Type 1 Diabetes

In an early clinical trial, researchers in the U.K. show treatments with peptides, fragments of proteins, are safe and can slow the progression of type 1 diabetes. . . . → Read More: Peptide Immunotherapy Shown Safe for Type 1 Diabetes

University Spins Off Educational Robot Start-Up

A start-up enterprise spun-off from Harvard University is developing a learning system with robotics to teach computer coding to students. . . . → Read More: University Spins Off Educational Robot Start-Up

Trial to Test Inhaled Insulin, App for Diabetes Mgmt

A clinical trial is planned to test the benefits of managing type 2 diabetes with an inhaled formulation of insulin and a smartphone app. . . . → Read More: Trial to Test Inhaled Insulin, App for Diabetes Mgmt

Migraine Treatment Shown Effective in Late Trial

Results of a clinical trial show a single dose of new drug relieved migraine pain among more people with the condition, compared to a placebo. . . . → Read More: Migraine Treatment Shown Effective in Late Trial